Commonwealth Equity Services, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$36.99 - $50.09 $167,897 - $227,358	-4,539 Reduced 44.54%	5,651 $274,000
Q2 2024 Jul 31, 2024	SELL	$38.65 - $43.48 $657 - $739	-17 Reduced 0.17%	10,190 $408,000
Q1 2024 Apr 29, 2024	BUY	$42.85 - $63.45 $224,791 - $332,858	5,246 Added 105.74%	10,207 $448,000
Q4 2023 Feb 06, 2024	SELL	$44.49 - $62.93 $218,001 - $308,357	-4,900 Reduced 49.69%	4,961 $307,000
Q3 2023 Oct 23, 2023	BUY	$45.51 - $65.0 $121,693 - $173,810	2,674 Added 37.21%	9,861 $454,000
Q2 2023 Aug 10, 2023	BUY	$35.77 - $58.38 $257,078 - $419,577	7,187 New	7,187 $413,000

279

36.8M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.58B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.